Graham Capital Management, L.P.
Position in ORGO — Organogenesis Holdings Inc.
CIK 1315421
ROWAYTON, CT
Position in ORGO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,122
New position
Shares Held
13,554
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Graham Capital Management, L.P. holds $4,664,055 across 12 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
75,653 | $1,212,717 | |
| 2 | HLN |
Haleon plc
|
55,057 | $513,681 | |
| 3 | BHC |
Bausch Health Companies Inc.
|
101,971 | $502,717 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
24,035 | $416,045 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
7,136 | $337,318 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
8,555 | $309,691 | |
| 7 | ZTS |
Zoetis Inc.
|
4,304 | $309,285 | |
| 8 | PRGO |
PERRIGO Co plc
|
28,290 | $293,933 |
All Filings in ORGO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,122 | 13,554 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||